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Abstract
Background
Cholera is endemic in Bangladesh, with outbreaks reported annually. Currently, the majority
of epidemic cholera reported globally is El Tor biotype Vibrio cholerae isolates of the ser-
ogroup O1. However, in Bangladesh, outbreaks attributed to V. cholerae serogroup O139
isolates, which fall within the same phylogenetic lineage as the O1 serogroup isolates, were
seen between 1992 and 1993 and in 2002 to 2005. Since then, V. cholerae serogroup O139
has only been sporadically isolated in Bangladesh and is now rarely isolated elsewhere.
Methods
Here, we present case histories of four cholera patients infected with V. cholerae serogroup
O139 in 2013 and 2014 in Bangladesh. We comprehensively typed these isolates using
conventional approaches, as well as by whole genome sequencing. Phenotypic typing and
PCR confirmed all four isolates belonging to the O139 serogroup.
Findings
Whole genome sequencing revealed that three of the isolates were phylogenetically closely
related to previously sequenced El Tor biotype, pandemic 7, toxigenic V. choleraeO139 iso-
lates originating from Bangladesh and elsewhere. The fourth isolate was a non-toxigenic V.
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004183 November 12, 2015 1 / 11
OPEN ACCESS
Citation: Chowdhury F, Mather AE, Begum YA,
Asaduzzaman M, Baby N, Sharmin S, et al. (2015)
Vibrio cholerae Serogroup O139: Isolation from
Cholera Patients and Asymptomatic Household
Family Members in Bangladesh between 2013 and
2014. PLoS Negl Trop Dis 9(11): e0004183.
doi:10.1371/journal.pntd.0004183
Editor: Ruifu Yang, Beijing Institute of Microbiology
and Epidemiology, CHINA
Received: February 11, 2015
Accepted: September 30, 2015
Published: November 12, 2015
Copyright: © 2015 Chowdhury et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files,
except for the genome sequence data, which are
deposited in the European Nucleotide Archive with
accessions ERS452533 – ERS452544.
Funding: This study was supported by a Grant
OPP50419 from the Bill & Melinda Gates Foundation
and National Institutes of Health (U01A1077883,
R01AI106878 and U01AI058935). Additionally, the
study was supported by the core grants of icddr,b.
icddr,b is thankful to the Governments of Australia,
cholerae that, by conventional approaches, typed as O139 serogroup but was genetically
divergent from previously sequenced pandemic 7 V. cholerae lineages belonging to the
O139 or O1 serogroups.
Conclusion
These results suggest that previously observed lineages of V. cholerae O139 persist in
Bangladesh and can cause clinical disease and that a novel disease-causing non-toxigenic
O139 isolate also occurs.
Author Summary
Vibrio cholerae serogroup O1 is thought to be the sole causative agent for cholera in Ban-
gladesh and most of the high risk developing countries. Whilst historically Vibrio cholerae
serogroup O139 has been seen to cause sporadic disease, the overall numbers of reported
O139 clinical cases are low, with none reported in Bangladesh since 2005. Here we report
four patients suffering from cholera attributed to serogroup O139 V. cholerae. Cases 1 and
2 were symptomatic (isolated strains 1, 2), and cases 3 and 4 were asymptomatic (isolated
strains 3, 4). All cases were from urban Dhaka and represented a range of age groups.
Cases 2–4 presented with no sign of dehydration whereas case 1 showed some signs of
dehydration. Phenotypic and whole genome sequence data indicates that one of the four
O139 V. cholerae isolates represents a novel O139 subtype. Since natural infection with V.
cholerae O1 or vaccination with currently available licensed cholera vaccines (e.g.,
Dukoral) provides little protection against O139, we conclude that V. cholerae O139
remains in circulation and is still causing a low incidence of cholera. Therefore, further
studies looking at the significance of these isolates towards the total burden of cholera
in Bangladesh is warranted, including clinical evaluation, genome sequencing and
immunobiochemistry.
Introduction
During 1992–93, V. choleraeO139 was first recognized in Bangladesh, India and other coun-
tries in Southeast Asia as a causative agent of epidemic cholera [1–3]. Prior to this, the O1 ser-
ogroup was considered the sole cause of cholera epidemics [4]. The isolation of O139 from
clinical cases declined quickly after the initial outbreak, with the exception of one epidemic in
August 2002 in Dhaka city [5]. Following on from this, isolates of the O139 serogroup were
also isolated sporadically from clinical and environmental samples from various regions of
Bangladesh during 2005, although no large-scale outbreaks of cholera attributed to O139
serogroup V. cholerae were reported during this time [5, 6]. Since then, clinical cholera in Ban-
gladesh has been caused entirely by the V. cholerae O1 serogroup, with an unexplained disap-
pearance of V. choleraeO139 [5].
With the recent publication of whole genome-based phylogenies of V. cholerae, we are able
to see how the isolates responsible for global cholera relate to each other [7]. It is clear from
these data that the isolates causing the current (seventh) pandemic of cholera form a highly
related monophyletic lineage dominated by isolates of the El Tor biotype and of the O1 ser-
ogroup. This phylogeny, based on whole genome sequence of clinical isolates, shows three
overlapping global expansions of V. cholerae since the pandemic began, denoted wave I, II, and
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III. From sequencing of a limited number of O139 isolates, it has been shown that they form a
single distinct phylogenetic branch that falls within wave II of the seventh pandemic El Tor
lineage [7]. At one time, O139 isolates were thought to represent a new lineage of V. cholerae
that would spread globally and perhaps even replace the O1 serogroup. Since the O139 ser-
ogroup of V. cholerae was first recognized, it has been included in cholera surveillance initia-
tives and in vaccine design efforts [1, 8]. However, pandemic wave II O139 and O1 serogroup
isolates are increasingly rare, being replaced almost exclusively by O1 serogroup wave III
strains, causing disease globally. Here we report the isolation, characterization and sequence
analysis of recent isolates of V. cholerae O139 recovered from stools of patients hospitalized at
the icddr,b diarrheal hospital, as well as from asymptomatic members of the patients’ house-
holds. The aim of this study was to compare these new V. cholerae O139 isolates to existing
O139 and O1 isolate sequence data to determine if these new cases were caused by new O139
variants, or the persistence of strains that belong to the known O139 lineage. This will inform
the management of future cholera epidemics.
Materials and Methods
Study area
This study was carried out in patients presenting to the icddr,b diarrheal hospitals in the Moha-
khali and Mirpur neighborhoods of Dhaka, as well as from asymptomatic household members
of the cholera patients between December 2013 to March 2014. These patients were enrolled
either from the systematic surveillance system for enteric pathogens at the icddr,b Mohakhali
hospital, through other ongoing cholera studies [9–11], or through passive surveillance for
cholera being conducted at these health facilities as part of a vaccination campaign with oral
killed cholera vaccine Shanchol in Dhaka, Bangladesh [11].
Patient and clinical data
Demographic, socioeconomic, and clinical data were obtained from all study participants.
Trained study staff or hospital physicians performed a clinical examination of all study partici-
pants. Study participants were assessed for degree of dehydration according to WHO guide-
lines [12] and treatment was provided according to the icddr,b protocols [13].
Collection of specimens and characterization of V. choleraeO139
isolates
All participants gave informed consent for collection of stool/rectal swab specimens. Rectal
swabs were collected from case 1 and case 3 because fresh stool specimens were not available.
Fresh stool specimens as well as stool swabs were collected from case 2 and case 4. All rectal
swabs were placed in a Cary Blair medium and transported to the icddr,b laboratory at room
temperature. Two swabs were obtained from each patient. In the laboratory, the first rectal
swab taken from each patient was cultured directly on to taurocholate tellurite gelatin agar
(TTGA) and the second swab was enriched in alkaline peptone water and incubated at 37°C
overnight [14]. After incubation and further culture on TTGA plates, suspected colonies
resembling V. cholerae were tested by slide agglutination with monoclonal antibodies specific
for V. cholerae O1 and O139 [15], as well as by biochemical assays. Specimens that were posi-
tive for V. choleraeO139 were stored at −70°C and later examined by a multiplex PCR assay
for concurrent detection of rfb sequences specific for O139/O1 genes of V. cholerae and for
ctxA-specific sequences [16]. Toxigenic V. choleraeO139 (CIRS 134B) and V. cholerae O1 El
Tor Inaba (strain N16961) and classical Inaba (strain 569B) serotypes were used as positive
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controls for the multiplex PCR assay. Strains were tested for antimicrobial resistance by disk
diffusion method using azithromycin, ciprofloxacin, ceftriaxone, erythromycin, mecillinam,
norfloxacine, nalidixic acid, trimethoprim sulfamethoxazole, and tetracycline.
The four V. cholerae O139 isolates were tested in the rabbit ileal loop assay [17] to detect
fluid accumulation and enterotoxicity. V. choleraeO1 strains 569B and N16961 were used as
positive controls. Detection of cholera toxin (CT) was performed by ganglioside GM1-specific
enzyme linked immunosorbent assays (ELISA) [18] and differentiation of classical and El Tor
biotype CT was made using MAMA PCR described previously [19]. Multiplex PCR assays
were performed on a Thermo cycler C-1000 instrument (Bio-Rad). Two sets of oligonucleotide
primer pairs were used. The first was O139 rfb-F (5´- AGCCTCTTTATTACGGGTGG-3´),
O139 rfb-R (5´-GTCAAACCCGATCGTAAAGG-3´), and the second one was ctxA-F
(5´-CTCAGACGGGATTTGTTAGGC-3´), ctxA-R (5´TCTATCTCTGTAGCCCCTATTA-3´);
these pairs were used to amplify O139 rfb (amplicon size 449 bp) and ctxA (amplicon size
302 bp) genes respectively using previously described procedures [16]. The product was ana-
lysed on 1% agarose gel using Gel Red (BioTium, USA) stain for visualization. Genomic DNA
was extracted from eight V. cholerae strains collected in Bangladesh; Strain 5, Strain 6, Strain 7
and Strain 8 in 1993 and Strain 9 to 12 in 2002 as well as the four V. choleraeO139 isolates col-
lected in 2013 and 2014. Genomic DNA was prepared by incubating a fresh V. cholerae colony
from a gelatin agar plate into 5 mL of LB broth with overnight shaking at 37°C at 150 rpm.
Genomic DNA was extracted with a DNA pure extraction kit (QIAGEN, Germany) according
to the manufacturer’s recommendations. Specimen DNA was stored at -70°C and shipped in
dry ice to the Wellcome Trust Sanger Institute for sequencing and whole genome analysis.
Whole genome sequencing and analysis
Isolates were sequenced as multiplexed libraries on an Illumina MiSeq machine, producing
150 nucleotide paired-end reads. Whole genome sequence analysis on the four V. cholerae
O139 isolates collected in 2013 and 2014 was carried out and compared with data from the
eight strains collected in Bangladesh in 1993 and 2002 (S1 Table).
The data generated were combined with previously published V. cholerae genome sequence
data [7] from representative O1 seventh pandemic El Tor global wave I, II and III strains, as
well as three wave II O139 seventh pandemic El Tor isolates, and used to construct a whole
genome single nucleotide polymorphisms (SNP)-based phylogeny. To achieve this, reads for
all isolates were mapped to the V. cholerae O1 El Tor strain N16961 (accession AE003852/
AE003853) reference sequence using SMALT v0.7.4 [20], and with GATK for indel realign-
ment [21]. SNPs were called using a combination of SAMtools [22] mpileup and BCFtools as
described previously [23]. SNPs falling in regions identified as being recombinant and so not
likely to reflect the underlying phylogeny of the bacterium were excluded from this analysis as
described in Croucher et al. [24] and a phylogenetic tree was drawn using the non-recombinant
SNPS with RAxML [25]. Draft de novo genome assemblies were created using Velvet [26] and
scaffolded using SSPACE [27] and Gap Filler [28].
Accession numbers
1. AE003852/AE003853
2. AAKF03000000
3. ERS452533 –ERS452544
4. ERS013124
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5. ERS013125
6. AB012956.1
7. Genes VC_0240 –VC_0264
Ethical considerations
The hospital surveillance activities of icddr,b were approved by the Research Review Commit-
tee (RRC) and Ethical Review Committee (ERC) of icddr,b. According to the icddr,b hospital
surveillance system, we only require verbal consent from patients undergoing routine investi-
gation for collecting stool specimens. Consent was documented in the surveillance question-
naire in the hospital surveillance system. Consent was also obtained in accordance with other
ongoing studies approved by the RRC/ERC of icddr,b (# PR-10061, # PR-11041)
Based on the above, verbal consent was obtained from one study participant (case 3) while
written informed consent was obtained from two cholera patients (cases 1, 2) and one asymp-
tomatic household contact (case 4).
Results
Demographic information
The socioeconomic status of the four cases was lower middle class and all were individuals who
lived in high risk settings in urban slums in and around Dhaka city. The annual income of the
adults (and the parent of the child; case 2) ranged from 15,000–30,000 Taka (~USD 200–300).
Two of the participants worked in garment factories while the other two families were self-
employed in small businesses. All of the cases reported that they consumed stored tap water in
their homes or workplaces and shared kitchens and toilets in the community.
Symptomatic cases with V. choleraeO139 infection
Case 1. A 26-year old male presented to the icddr,b, diarrheal hospital in Mirpur Treat-
ment center Dhaka, Bangladesh on November 24, 2013 with 12 hours of sudden onset of
voluminous diarrhea and vomiting. The patient was a participant in a large cholera vaccine fea-
sibility study. Surveillance was carried out as part of the ongoing hospital-based passive surveil-
lance for cholera. The patient had experienced nine episodes of diarrhea, vomited twice, and
ingested a liter of oral rehydration fluid prior to admission. He lived in an urban slum located
in Mirpur, in Dhaka. The patient's past medical history was unremarkable. On admission, no
other family member of the patient was suffering from severe diarrhea. On examination, the
patient was less active, was thirsty, had sunken eyes, dry buccal mucosa, normal skin turgor,
normal breathing, and a low volume pulse and showed signs of some dehydration. Other sys-
temic findings were normal. Upon admission, the patient was treated with a single 1 gm oral
dose of azithromycin as per icddr,b treatment guidelines. Stool culture, followed by slide agglu-
tination with monoclonal antibodies specific for O139 or O1 indicated V. cholerae serogroup
O139 was the causative agent.
Case 2. A 16 month old child was brought to the icddr,b hospital, Mohakhali, Dhaka on
March 4, 2014 with 3 days of diarrhea. He had travelled from Savar, 20 km from Dhaka city, to
the icddr,b, Mohakhali Hospital for treatment and was enrolled as part of the systematic sur-
veillance system of the icddr,b hospital. Since onset, the patient had experienced several epi-
sodes of diarrhea and ingested oral rehydration solution at home. On examination, the patient
demonstrated no sign of dehydration and other systemic findings were normal. However, clini-
cal examination showed that the child was undernourished (Z score -1.43). Stool culture tested
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positive for V. cholerae and phenotypic tests confirmed the serogroup as O139. No other V.
cholerae serogroup or enteric pathogens were detected.
Isolation of V. cholerae serogroup O139 from asymptomatic household
contacts of patients with clinically confirmed cholera
Case 3. On December 26, 2013, a 52 year old man, a healthy household contact of a chol-
era positive index case from the cholera vaccine study in Mirpur, Dhaka was diagnosed with V.
cholerae O139 infection. This was detected during a home visit to a cholera positive index case.
The patient’s spouse had been admitted to the diarrheal hospital of icddr,b in Mirpur, a week
prior to the home visit with cholera caused by V. cholerae O1. During the home visit, stool
specimens were obtained from three household contacts of the index case. Of the three subjects
sampled, one was culture positive for V. cholerae O139. He was asymptomatic with no sign of
dehydration and was otherwise clinically healthy.
Case 4. A 21 year old female, a household contact of a V. cholerae O1 infected cholera case
was also diagnosed with asymptomatic V. cholerae O139 infection in 25th February 2014. Her
husband had previously been admitted to the icddr,b hospital with a history of 3 days of diar-
rhea and diagnosed with cholera due to V. cholerae O1, presenting with severe dehydration.
The female household contact was asymptomatic with no other clinical signs of having a diar-
rheal disease.
Further characterization of the V. choleraeO139 isolates: Phenotypic
and molecular characteristics
The four V. choleraeO139 isolates (strains 1–4) collected in this study, having tested strongly
positive for the O139 lipopolysaccharide (LPS) O-antigen by the rapid dipstick assay, according
to the manufacturer’s recommendations (Span Diagnostics Ltd., India), were further character-
ized. The serogroup was further confirmed: all four O139 isolates were found to be positive for
the O139 rfb gene. PCR was used to assay for the presence of the cholera toxin gene, ctxA.
Strains 2, 3 and 4 were found to be positive for ctxA, all of which when sequenced were charac-
teristic of the classical biotype (see methods). The production and type of toxin was further
confirmed by ELISA. The serogroup O139 isolates taken from case 1 (strain 1) was negative for
both the classical and El Tor biotype of cholera toxin by both PCR and ELISA. The rabbit ileal
loop assay to detect fluid accumulation and enterotoxicity showed that three O139 strains were
strongly positive for toxin production (strains 2–4), while the isolate from case 1 (strain 1)
failed to induce fluid accumulation and enterotoxicity in the rabbit ileal loop. All four V. cho-
leraeO139 isolates were found to be resistant to nalidixic acid but were sensitive to all of the
other antibiotics tested.
Whole genome sequence and phylogenetic analysis of the O139
isolates
To understand the detailed genetic relationships between the O139 isolates taken from these
four patients, we extracted the DNA and sequenced their genomes. For comparison, we also
sequenced an additional eight O139 isolates taken in Bangladesh in previous outbreaks in 1993
and 2002. For the isolates obtained from cases 2, 3, and 4, 95.6% of their sequence read data
mapped to the genome of the V. cholerae pandemic 7 strain N16961 serogroup O1 reference
sequence (S1 Table). These three genomes differed by between 112–114 (313–316 before
removing putative recombination) single nucleotide polymorphisms (SNPs) from the reference
sequence. When compared to the O139 strain MO10 (accession AAKF03000000) mapped to
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the N16961 reference sequence, there were between 46–47 SNPs differentiating MO10 from
these three isolates. To determine the phylogenetic relationship of the V. cholerae O139 isolates
we constructed a whole genome core phylogeny from these three V. cholerae O139 isolates
taken from cases 2–4 along with the O139 isolates collected in previous years, and including
those previously described [7]. The sequence data are deposited in the European Nucleotide
Archive with accessions ERS452533 –ERS452544. The phylogenetic relationships of the isolates
sequenced in this study, with the exception of that from case 1, are consistent with previous
data [7]. Fig 1 shows that the majority of the isolates fell in the O139 branch of the seventh pan-
demic El Tor phylogenetic tree, along with the previously published O139 sequences from
India and Bangladesh (accessions ERS013124, ERS013125, AAKF03000000) and the majority
of isolates sequenced in this study. The new O139 sequences, with the exception of the 2013
isolate from case 1, cluster with a strong temporal signature with isolates in the previous study
[7] including the MO10 isolate from India in 1992.
Whole genome analysis of the non-toxigenic 2013 strain (isolated from case 1) was distinct,
with only 83.6% of the sequence reads mapping to the N16961 reference genome, and showing
98,743 and 97,313 (approximately 124,200 and 122,400 before removing putative recombina-
tion) SNP differences when compared to N16961 or MO10 using the mapping to the N16961
genome, respectively. The genome sequence data showed that the case 1 isolate (strain 1)
Fig 1. Mid-point rootedmaximum likelihood phylogeny of V. choleraeO139 isolates from this study, excluding the isolate from case 1 (strain 1) but
including previously published V. cholerae isolates. The scale bar represents the number of single nucleotide polymorphisms.
doi:10.1371/journal.pntd.0004183.g001
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lacked the ctxAB genes but possessed the O139 specific rfb gene, confirming the PCR and phe-
notypic results described above. Based on the mapped genome data, this isolate was highly
divergent from all other sequenced O1 and O139 isolates in this study and described previ-
ously. Although this isolate was confirmed as belonging to the O139 serogroup using tradi-
tional techniques, sequence analysis showed that the genes for the O-antigen biosynthesis
genes of this isolate were different from both the O1 and other O139 isolates. To investigate
this in greater detail, the 84 contigs of the previously sequenced O139 cholera isolate MO10
were ordered against the O1 N16961 reference using ABACAS [8]. The Artemis Comparison
Tool [29] was used to compare the ordered MO10 genome against the case 1 genome; the con-
tiguated sequence of one area of the LPS operon in the case 1 isolate was used to correct the
ordering of one of the MO10 contigs. A search in the NCBI database using blastn [30] of the
LPS operon sequence of the MO10 isolate found a hit against a 46.7kb sequence of Vibrio cho-
lerae genes for O-antigen synthesis, O139 strain MO45 (accession AB012956.1). Comparative
sequence analysis of the O139 O-antigen biosynthesis genes in the case 1 isolate showed that it
was distinct from those within the O1 N16961 and O139 MO10 isolates, MO45 O-antigen bio-
synthesis genes, and the O-antigen biosynthesis genes from the genome obtained from case 3
in this study (Fig 2).
Discussion
We report the isolation and characterization of four isolates belonging to the V. cholerae ser-
ogroup O139 in an eleven month period between December 2013 and March 2014 in Dhaka,
Bangladesh. This represents the first report in Bangladesh since 2005 of clinical cases of cholera
caused by V. choleraeO139 infection. This included two patients who presented with acute
diarrhea who were ultimately hospitalized.
To put these four isolates in context, icddr,b conducts epidemiological and ecological sur-
veillance for cholera in different parts of Bangladesh. Between 2010–2012, 500 clinical and
environmental V. cholerae strains were isolated, 496 were confirmed as O1 and four as V. cho-
leraeO139; all of those four previous O139 isolates were obtained from environmental samples
[5]. Given the association between V. cholerae O139 and previous epidemics, the persistence
and newly identified sporadic cases of both toxigenic and non-toxigenic V. choleraeO139 in
the environment and in symptomatic and asymptomatic infections is notable, and may have
future implications for the diagnosis and prevention of cholera in this region. Recently, a strain
of V. choleraeO139 was isolated from a cholera patient in Beijing in China in May 2014 [31]
highlighting the continued low level presence of this lineage in different locales.
Interestingly, in two of our patients, V. cholerae O139 strains were isolated from asymptom-
atic household members of V. cholerae O1 infected cholera patients. In our previous studies,
we have shown that household contacts of an index case of cholera are approximately three
times more at risk of infection with V. cholerae [11]. However, we have previously identified
non-O1/non-O139 isolates in household members of patients with O1 cholera [32] or even a
different O1 Inaba or Ogawa serotype from that isolated from an index case. The V. cholerae
O139 strains presented here were only resistant to nalidixic acid and therefore differ from the
V. cholerae O1 that currently predominate global infections, which are also resistant to tri-
methoprim-sulfamethoxazole and tetracycline [31].
Whole genome sequence analysis showed that isolates from cases 2–4 fell on the O139
branch of the seventh pandemic El Tor phylogenetic tree, along with the previously
published O139 sequences from India and Bangladesh (accessions ERS013124, ERS013125,
AAKF03000000) [7]. These data also highlighted the existence of one isolate, from case 1,
that was typed genotypically and phenotypically as serogroup O139, but phylogenetically
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represented a distant non-El Tor pandemic 7 V. cholerae lineage. By comparing the LPS O-
antigen operons it was apparent that this isolate, although highly divergent from the previously
sequenced O139 isolates, possessed part of the O139 O-antigen gene cluster both targeted by
the diagnostic O139 PCR test and which phenotypically appears sufficient to produce a O139
positive result by ELISA and the rapid dipstick typing methods. Further work will be required
to determine fully the significance of this subtype to human health. At the time of writing this
report, we had isolated two more strains of V. cholerae O139 from patients hospitalized with
cholera between October and November 2014. These strains are being further characterized at
present, and preliminary data suggest that they are phenotypically and genotypically similar to
the isolate from case 1.We are at present carrying out detailed analysis of these strains using
genomic techniques.
In summary, our data suggest that V. cholerae O139 strains persist not only within the envi-
ronment, but also are associated with occasional causes of acute watery diarrhea. Since previous
infection with V. cholerae O1 does not provide protection against O139, and vice versa, our
data suggest that O139 could re-emerge as a significant cause of cholera in areas where the
pathogen persists. Of note, oral killed cholera vaccine Shanchol is bivalent, and contains com-
ponents of both O1 and O139 organisms, while other currently commercially available cholera
Fig 2. Multi-genome comparison using the Artemis Comparison Tool [29] showing the similarity and synteny of the O-antigen biosynthesis genes
(coloured orange) of the O1 N16961 reference sequence (genes VC_0240 –VC_0264), and the draft de novo assemblies of the O139 MO10, the
O139 from strain 3 in this study, the O-antigen biosynthesis genes from O139 MO45, and the O139 from strain 1 in this study.Grey blocks indicate
genetic similarity; vertical red lines indicate contig breaks in the draft assemblies. The PCR product of the primer sequences used in this study to identify
O139 is shown in green in the genome sequence from strain 1.
doi:10.1371/journal.pntd.0004183.g002
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vaccines are monovalent, providing protection against O1 alone. We are continuing with the
surveillance of patients with acute watery diarrhea for detection of V. cholerae O139 to monitor
emergence of new variants and also to detect any new and reemerging outbreaks or epidemics
using microbiological and genomic analysis. This is extremely important for planning future
strategies for immunoprophylactic preventive measures.
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